Live
- GAIL clocks net profit of Rs 2,672 crore in Q2
- Sr Men's National Hockey: Delhi, Karnataka, Bengal, A.P. win group matches on Day 2
- ‘Nation is proud of you’: West Bengal Guv to GRSE on laying keels of two NGOPVS
- Kirttane, Kapadia bag golden double as India wins 14 medals in Asia Pickleball Games
- Gurugram: 11 projects of GMDA worth Rs 249.77 crores approved
- SVICCAR Tirupati Hosts Event to Enhance Awareness for Palliative Care
- Akali Dal stages statewide protests over ‘tardy’ paddy procurement in Punjab
- Firing on Nandan Kanan Express in Odisha, probe launched
- Indian Army Seizes Massive Cache Of Arms And Ammunition In Manipur Amid Ongoing Violence
- Polling Stations Open Across Eastern And Central US As Voters Head To The Ballots In Historic Election
Why cheaper medicines not being promoted: Parl panel
Why cheaper medicines not being promoted: Parl panel
A parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and prices of expensive medicines pushed by pharma companies, sources said. During a meeting of the Parliamentary Standing Committee on Home Affairs, members demanded that the maximum price of COVID-19 medicines be capped, they said.
New Delhi: A parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and prices of expensive medicines pushed by pharma companies, sources said. During a meeting of the Parliamentary Standing Committee on Home Affairs, members demanded that the maximum price of COVID-19 medicines be capped, they said. Home Secretary Ajay Bhalla, Joint Secretary in Health Ministry Lav Agarwal and other officials were present in the meeting chaired by Congress leader Anand Sharma.
Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment, sources in the panel said.
The committee members expressed concern over black marketing of medicines.Naming three cheaper and easily available medicines, the committee members questioned why are they not being promoted despite being equally effective.
